Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Aloe Vera Mouthwashes on the Oral Health of Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04009616
Recruitment Status : Active, not recruiting
First Posted : July 4, 2019
Last Update Posted : July 18, 2019
Sponsor:
Information provided by (Responsible Party):
Damascus University

Brief Summary:

Prevention of dental problems by controlling plaque is the best solution to maintain oral health and prevent high cost of dental treatments. Home oral care is the cornerstone in removing plaque and therefore controlling tooth decay and gum disease. Unfortunately, complete plaque removal is difficult to achieve by mechanical methods alone.

For effective plaque control antiplaque agents such as chlorhexidine mouthwash is necessary. Chlorhexidine has shown distinct advantage, but it has many side effects such as staining of the teeth and the tongue, altered taste sensation, and increased calculus formation often deters its use for long periods.

Recently the use of herbal mouthwashes is rising due to the widespread awareness that natural substances have less side effects and lower economic cost. Of various plant extracts used as a base for mouthwashes, aloe vera deserves a special attention as it has recently been introduced in dentistry after years of use in medicine field.

Many recent studies stated that aloe vera mouthwashes has shown efficiency in plaque control and prevention of gingivitis, but there is a need for more studies to determine the best protocols regarding concentration and frequency of its use. A review of the literature shows that there is no randomized controlled trials evaluating its efficiency in plaque control and prevention of gingivitis in children, which is the main purpose of this study.


Condition or disease Intervention/treatment Phase
Oral Health Drug: Aloe Vera mouthwash Drug: Chlorhexidine mouthwash Drug: Placebo mouthwash Not Applicable

Detailed Description:

The crossover design will be adopted in this study, i.e. the three types of mouthwashes (experimental "aloe Vera", positive control "chlorhexidine", negative control "placebo") will be utilized for all participants, with an equal (5) days application period for each type of mouthwashes and a wash-out period of (12) days between each type to ensure the elimination of the effects of a mouthwash before moving to the next one.

The evaluation areas selected for the study comprised the central maxillary incisors and the first maxillary molars.

A special plaque guard will be fabricated to cover the evaluated teeth and their gingival margins, this plaque guard will prevent plaque removal of the evaluated teeth and facilitate localized plaque accumulation and the resultant gingivitis if any.

At the start of the study, all participants will be instructed on how to brush their teeth properly and continue their regular oral hygiene.

All subjects will be instructed to wear the plaque guards every time they cleaned their teeth, so that they will not brush the maxillary incisors and the maxillary first molars. This phase "the accumulation phase" will last for 3 days, and then the subjects will be recalled to assess the difference in plaque accumulation on the 5th day.

The following indices will be studied: Plaque index (PI) to assess the plaque accumulation, gingival index (MGI),and bleeding index (BI)to assess gingivitis. These indices will be recorded at the first and in the 3th day. The "rinsing phase" will begin from the morning of day 4 and last for 5 days.

15 ml of rinsing solution will be given to each subject who is not aware of what type of mouthwash he/she is receiving. Along with each bottle of mouthwash, a 10 ml syringe will be used to facilitate determining correct dosage. The subjects will be asked to rinse with 15 ml of the solution for 1 min, once daily. Intake of food and/or drinks will not be allowed for 2 hours after rinsing. The subjects will be recalled for evaluation of plaque accumulation once the "rinsing phase" is completed on 8th day.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 17 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Effect of Aloe Vera Mouthwashes on Plaque and Gingivitis Indices in Children (Clinical Randomized Controlled Trial)
Actual Study Start Date : March 1, 2019
Actual Primary Completion Date : June 30, 2019
Estimated Study Completion Date : July 30, 2019


Arm Intervention/treatment
Experimental: Aloe Vera mouthwash

plaque accumulation and gingivitis will be evaluated before and after giving aloe vera mouthwash by studying plaque, gingival and bleeding indices.

the plaque will be accumulated for 3 days "accumulation phase" before applying aloe vera mouthwash for 5 days "rinsing phase".

Drug: Aloe Vera mouthwash
rinsing with aloe vera mouthwash for 5 days.

Experimental: Chlorhexidine mouthwash

plaque accumulation and gingivitis will be evaluated before and after giving chlorhexidine mouthwash by studying plaque, gingival and bleeding indices.

the plaque will be accumulated for 3 days "accumulation phase" before applying chlorhexidine mouthwash for 5 days "rinsing phase".

Drug: Chlorhexidine mouthwash
rinsing with chlorhexidine mouthwash for 5 days.

Placebo Comparator: Placebo mouthwash

plaque accumulation and gingivitis will be evaluated before and after giving placebo mouthwash by studying plaque, gingival and bleeding indices.

the plaque will be accumulated for 3 days "accumulation phase" before applying placebo mouthwash for 5 days "rinsing phase".

Drug: Placebo mouthwash
rinsing with placebo mouthwash for 5 days.




Primary Outcome Measures :
  1. Effect of Aloe vera mouthwashes on plaque index [ Time Frame: before accumulation phase (at the 1st day), before rinsing phase (at the 3rd day) and after rinsing phase (at the 8th day) ]
    this variable will be measured by calculating the difference between the index studied at the beginning and end of the experimental phase, to evaluate children's oral health and know the probability to have caries later.

  2. Effect of Aloe vera mouthwashes on gingival index [ Time Frame: before accumulation phase (at the 1st day), before rinsing phase (at the 3rd day) and after rinsing phase (at the 8th day) ]
    this variable will be measured by calculating the difference between the index studied at the beginning and end of the experimental phase, to evaluate children's gingival health and know the probability to have gingivitis later.

  3. Effect of Aloe vera mouthwashes on gingival bleeding index [ Time Frame: before accumulation phase (at the 1st day), before rinsing phase (at the 3rd day) and after rinsing phase (at the 8th day) ]
    this variable will be measured by calculating the difference between the index studied at the beginning and end of the experimental phase, to evaluate children's gingival health and know the probability to have gingivitis later.


Secondary Outcome Measures :
  1. the level of receptivity and discomfort and side effects of the Aloe vera mouthwashes. [ Time Frame: at the end of each mouthwash experimental phase (8th day) ]
    Assessment will be performed using questionnaire that includes Visual Analog Scale (VAS) for each question, the scale has a minimum scale of 0 (no discomfort) and a maximum scale of 100 (maximum discomfort).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   8 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Patient ages between (8 - 12) years.
  2. Healthy children without any systemic medical conditions.
  3. Good oral health (no manifestations of oral diseases on the mucous membranes).
  4. The presence of the maxillary first permanent molars and the maxillary central incisors.
  5. No caries on the buccal and lingual surfaces of the teeth.
  6. Cooperative children (positive or definitely positive on Frankl's behavior rating scale).
  7. The patient has the physiological ability to use the mouthwashes, This will be confirmed by asking the child's parent first and then test his/her ability to rinse with water before being enrolled in the study.

Exclusion Criteria:

  1. Children with systemic medical conditions.
  2. Patients undergoing current dental or orthodontic treatment.
  3. Patients who used any other mouthwash during the study period or were given antibiotic therapy within 2 weeks before starting the study or corticosteroids within 30 days before starting the study.
  4. Patients who use removable prosthetic or orthodontic appliances.
  5. Patients who have gingival pockets more than (3) mm or advanced gingival diseases.
  6. Fluorescent patients.
  7. Patients who have a sensitivity story for any element of the mouthwashes used in the study.
  8. Patients who underwent an extraction within two weeks of starting the study.
  9. Patient lack of commitment toward follow-up appointments.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04009616


Locations
Layout table for location information
Syrian Arab Republic
Faculty of Dental Medicine, Damascus University
Damascus, Syrian Arab Republic
Sponsors and Collaborators
Damascus University
Investigators
Layout table for investigator information
Principal Investigator: Doaa Adnan Alnouri, DDS, Msc Student Department of Pediatric Dentistry, Faculty of Dental Medicine, Damascus University, Damascus, Syria
Study Chair: Chaza Kouchaji, Professor Department of Pediatric Dentistry, Faculty of Dental Medicine, Damascus University, Damascus, Syria
Study Chair: Abdul Hakim Nattouf, Professor Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syria

Publications:
Layout table for additonal information
Responsible Party: Damascus University
ClinicalTrials.gov Identifier: NCT04009616     History of Changes
Other Study ID Numbers: Doaa Alnouri
First Posted: July 4, 2019    Key Record Dates
Last Update Posted: July 18, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No

Keywords provided by Damascus University:
Aloe vera mouthwash

Additional relevant MeSH terms:
Layout table for MeSH terms
Chlorhexidine
Chlorhexidine gluconate
Anti-Infective Agents, Local
Anti-Infective Agents
Disinfectants
Dermatologic Agents